WinZO disputes Google's CCI proposal on Play Store rules
WinZO
has raised concerns over Google's latest proposal to the
Competition Commission of India
(CCI), arguing that it does not adequately address the anti‑competitive issues flagged in an ongoing investigation.
The case originates from WinZO's December 2022 complaint alleging that Google abused its dominant position by restricting Play Store access to only fantasy sports and rummy apps while excluding other real‑money gaming categories. With Google controlling 96% of India's app distribution market, WinZO said this policy inflated user acquisition costs by 'at least 10x' for apps distributed outside the Play Store.
Acting on the complaint, the CCI in November 2024 ordered a formal investigation, citing prima facie violations of competition law, including the imposition of unfair conditions, denial of market access and limiting of market development. The Commission had noted Google's lack of clear criteria for its pilot programme, inconsistent enforcement of its ads policy and 'misleading payment warnings' shown to users sideloading apps, which it said artificially deterred usage.
In a public notice issued recently the CCI invited comments on Google's commitment offer. Google's proposal includes allowing all real‑money games that are certified by recognised third‑party bodies, replacing its pilot programme for fantasy sports and rummy apps and permitting certified skill‑based games to advertise on Google Ads. If approved, Google has committed to implement the Play Store changes within 120 days and its advertising changes within 150 days of the CCI's order. The deadline for public comments is August 20, 2025.
Responding to WinZO's objections, a Google spokesperson said the company welcomed the CCI's market testing of its proposed framework, describing it as the result of 'constructive discussions' with the regulator and Indian developers. Google added that it is confident the proposal will create 'a more open and safe ecosystem' for real‑money gaming apps, empower local developers and prioritise user safety.
In its statement, WinZO said Google's commitments 'must be robust and genuinely eliminate the discriminatory practices identified,' adding that the proposed framework's reference to 'developing' a commercial model for real‑money gaming lacked clear timelines or objective criteria.
WinZO, which reported a 70% rise in revenue to Rs 1,055 crore and a 151% increase in profit to Rs 315 crore in FY24, said it will continue to participate in the consultation process 'to ensure fairness, transparency and a level playing field in India's digital economy.'
AI Masterclass for Students. Upskill Young Ones Today!– Join Now
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
4 minutes ago
- The Hindu
Russia is not Iran, India can't cancel oil imports on U.S. demand: experts
India cannot cancel oil imports from Russia as it did six years ago with Iran and Venezuela, given the difference in the scale and importance of the relationship, said experts, warning that the U.S.'s actions against India were damaging the relationship built over decades. In 2018, U.S. President Donald Trump had in his first term, demanded that India 'zero out' its oil imports from Iran and Venezuela. India had eventually complied with the demand before the deadline in May 2019. On Wednesday, Mr. Trump signed an executive order levying a 25% penalty on top of 25% tariffs on Indian goods, unless India cut energy purchases from Russia, which currently make up more than 35% of its oil imports. The penalty would kick in by August 27 unless Russia stops the war in Ukraine. The threat is expected to add pressure on both India and Russia ahead of a meeting between Mr. Trump and President Vladimir Putin next week, and the upcoming visit by Mr. Putin to India for the annual summit with Mr. Modi. 'At the global level, Russia is not Iran,' former Indian Ambassador to the U.S. Arun Singh told The Hindu in an interview. 'We want Russia, as one of the major powers in the international context, to be an important partner of India, and there's a memory in India of Russia in the past having provided political support [and] ...defence technology that nobody else was willing to provide,' he added, also warning that if India were to cave in to Mr. Trump's demands, this would only increase the U.S.'s appetite to demand more concessions from India. According to scholar Brahma Chellaney, the U.S. move on Russian oil is a cover to strong-arm India into accepting trading terms the U.S. wants, including market access for agricultural products. '[Mr.] Trump is weaponising Russian oil purchases to force a largely one-sided trade deal on India,' said Mr. Chellaney, who is a Professor of Strategic Studies at the New Delhi-based Center for Policy Research and Fellow at the Robert Bosch Academy in Berlin. He pointed out that technically, the U.S. has not sanctioned Russian oil, nor has it subscribed to the European Union's latest price cap on it. Mr. Trump had also not penalised China, which is the world's largest importer of Russian oil. 'Cutting Indian purchases of Russian oil is unlikely to make him back off. He wants a trade deal on his terms,' Mr. Chellaney added. Until recently, India imported about 2 million barrels a day, and is the second largest importer of Russian oil. Mr. Singh pointed to the past 25 years as a period of building trust between the two countries, and a steady improvement in relations after the previous era, where India had seen the U.S. as a 'coercive and an unreliable partner' for its backing of Pakistan, the 1971 Bangladesh War intervention, and the 1998 sanctions on India for its nuclear tests. Since 2008, after the U.S. helped India win exemptions at the International Atomic Energy Agency and the Nuclear Suppliers Group for doing nuclear trade, he said this perception seriously changed. He also said that the U.S. had supplied drones and winter clothing to support Indian forces during the India-China stand-off at the Line of Actual Control at 'short notice'. 'But because of what President Trump has done in India, there's a resurrection of the old and bitter memories of the U.S.,' Mr. Singh who is a Senior Fellow at Delhi-based Carnegie India and a Professor at Ashoka University. 'So President Trump and the U.S. may feel that they are putting some penalties on India, high tariffs, I would say that they are putting high tariffs and penalties, less on India, and more on the U.S.-India relationship. It will take some time for the relationship to come out from this shock that has been generated', he added.
Indian Express
4 minutes ago
- Indian Express
SBI Q1 profit jumps 12.48% to Rs 19,160 crore
The country's largest lender, State Bank of India (SBI), on Friday reported a 12.48 per cent growth in its net profit at Rs 19,160 crore during the quarter ended June 2025, compared to Rs 17.035 crore in the year-ago period. 'There has been a good containment of operating expenses. Besides, on a year-on-year basis, our treasury gains have also added to profit,' Setty said. While the bank was able to maintain its core net interest income, it did not see a major fall in its net interest income (NII), despite almost 30 per cent of the book being repriced immediately on the external benchmark linked lending rate (EBLR) front, he said. Following a 100 basis points (bps) cut in the repo rate between February and June 2025, all loans linked to the repo rate have been reduced by a similar margin. The bank's non-interest income jumped 55 per cent, on back of a 352 per cent growth in forex income. The lender's net interest income fell marginally by 0.13 per cent to Rs 41,072 crore. Net interest margin (NIM) of the lender dropped by 33 basis points (bps) to 3.02 per cent in Q1FY26, compared to 3.35 per cent in the year-ago period. Setty said the growth in NIM is likely to be U-shaped, with moderation in Q1 and Q2, and pick up in the fourth quarter of the current fiscal. Gross non-performing loans (NPAs) improved to 1.83 per cent from 2.21 per cent, and net NPA stood at 0.47 per cent, as against 0.57 per cent. The bank's gross advances increased by 11.61 per cent to Rs 42,54,516 crore and domestic advances registered a growth of 11.06 per cent. Loans to small and medium enterprises (SME) grew by 19.1 per cent, followed by agri advances which rose 12.67 per cent. Retail personal advances grew by 12.56 per cent. The bank's corporate advances recorded a slower growth of 5.7 per cent on y-o-y basis and a quarter-on-quarter decline of 3 per cent. Setty attributed the muted growth in corporate loans to delay in investment decisions due to tariff related uncertainties, shift by companies from banks to market instruments for funding and on account of pre-payments. 'We have seen that the utilisation of working capital which was 62 per cent in Q1 of FY25 has come down to 58 per cent now. Also, we have seen that some of the large corporates are accessing the commercial paper (CP) market basically to replace the working capital limits,' the SBI chairman said. He expects the corporate loan book to grow at 10 per cent in the third quarter of FY26. The bank has a total corporate loan book pipeline of Rs 7 lakh crore. Commenting on the impact of the higher tariffs on the banking system, Setty said banks have limited exposure to sectors likely to be affected. These include leather, chemicals, footwear, gems and jewellery, textiles and shrimp. The bank's share price closed at Rs 804.55 apiece, down 0.09 per cent on Friday after the quarterly results were declared.
Hindustan Times
4 minutes ago
- Hindustan Times
Mumbai Real Estate: Blue Jet Healthcare promoter family buys three Worli luxury apartments for more than ₹202 crore
In yet another sign of pharma wealth flowing into Mumbai's luxury real estate, the promoter of Blue Jet Healthcare and his family have purchased three high-end apartments in Worli for over ₹202 crore, according to property registration documents accessed by Zapkey. Blue Jet Healthcare promoter and family have bought three Worli luxury properties worth over ₹ 202 crore, signaling rising pharma wealth in Mumbai's high-end real estate. (Photo for representational purposes only)(Mehul R Thakkar/HT) Akshay Bansarilal Arora, promoter of the pharma company, bought two units in the super-luxury skyscraper Palais Royale from Honest Shelters Pvt Ltd. Each apartment measures 7,669 sq ft, comes with five car parking spaces, and was purchased for ₹57.14 crore. Akshay Bansarilal Arora and Honest Shelters Pvt Ltd could not be reached for a comment. In a separate deal, Shiven Akshay Arora, acquired a 7,747 sq ft apartment in Raheja Artesia, Worli, for ₹88 crore. The residence includes six parking spaces, the documents showed. Shiven Akshay Arora and Raheja could not be reached for a comment. Worli in central Mumbai has become a hotspot for several luxury projects after South Mumbai, Lower Parel, Prabhadevi, and Bandra. The micro market has several projects in the above ₹1 lakh per sq ft price range. Other pharma deals in Mumbai Pharmaceutical firm USV's chairperson, Leena Gandhi Tewari, has bought two luxury sea-facing duplex apartments in Mumbai's posh Worli area for ₹639 crore. She spent almost ₹63.9 crore in stamp duty and GST, bringing the total value of the transaction to about ₹703 crore, making it the most expensive residential property deal recorded in the country. The transaction underscores a significant uptick in luxury housing demand, particularly from the pharmaceutical sector. Real estate experts believe the post-COVID wealth surge has prompted many pharma promoters and executives to view high-end properties as both a secure investment and a status symbol. 'Pharma wealth is increasingly flowing into real estate,' said industry experts. The Zydus Family Trust, associated with Zydus Lifesciences Limited (formerly Cadila Healthcare Limited), a leading Indian pharmaceutical company, has purchased a ₹200 crore luxury apartment in Mumbai's Worli earlier this year. Last year, Vibha Shanghvi, wife of Dilip Shanghvi, chairman and managing director of Sun Pharma has purchased two apartments worth ₹130 crore in Mumbai's Worli area, according to documents accessed by Zapkey. Also Read: Vibha Shangvi, wife of Sun Pharma CMD purchases two apartments in Mumbai's Worli for ₹135 crore
